# Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke

> **NCT02586233** · PHASE1,PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 106 (actual)

## Conditions studied

- Acute Ischemic Stroke
- Thrombotic Disease

## Interventions

- **DRUG:** DS-1040b
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02586233
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2019-08-13
- **Final completion:** 2019-08-13
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02586233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02586233, "Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02586233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*